Publication | Closed Access

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaAlfa GroupPharmacotherapyAdult T-cell Leukemia-lymphomaMedicineRadiation OncologySafety ProfileHigh EfficacyHealth Sciences